Enact Holdings, Inc. logo ACT - Enact Holdings, Inc.

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY
0
BUY 3
HOLD 5
SELL 0
STRONG
SELL
0
| PRICE TARGET: $45.00 DETAILS
HIGH: $50.00
LOW: $40.00
MEDIAN: $45.00
CONSENSUS: $45.00
UPSIDE: 5.31%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Banks, Insurers & Asset Managers 85% confidence

Primary model: P/Tangible Book × ROE Quality

Valuation Signal Undervalued Strong
Trading 55.4% below fair value
Current Price $42.73
Bear Case $60.66 42.0% upside ($60.66 - $42.73) / $42.73 = 42.0% ROTCE 9.4% → 1.79x TBV
Fair Value $95.75 124.1% upside ($95.75 - $42.73) / $42.73 = 124.1% ROTCE 12.6% → 2.83x TBV
Bull Case $116.80 173.4% upside ($116.80 - $42.73) / $42.73 = 173.4% ROTCE 14.5% → 3.45x TBV

Adjust Assumptions

12.6%
7.0%

Key Value Driver

ROTCE (12.6%) vs. cost of equity (7.0%)

Implied Market Multiple 1.11x

Plain-Language Summary

Our base-case estimate uses P/Tangible Book × ROE Quality. We then blend that result with the average analyst price target of $45.00 from 8 analysts, using a 20% weight on analyst consensus. That produces an estimated intrinsic value of $95.75 per share.

Warnings

Traditional cash flow models don't work well for banks — lending activity distorts how much cash the business actually generates.
Common valuation shortcuts don't apply here — for banks, interest payments are a core business cost, not overhead.
Wall Street's average price target is $45.00 (from 8 analysts). Our estimate is 141% above the consensus -- consider that gap carefully.

Key Risks

  • Book value quality matters as much as level — check loan loss reserves
  • Interest rate sensitivity creates non-linear earnings surprises
  • Insurance reserving is actuarial, not financial — errors emerge slowly